Anti-PD-1 Antibody Combined With Autologous DC and NK Cells in the Treatment of Digestive Carcinoma
Clinical trial NCT05461235 · UNKNOWN
Trial details
- NCT number
- NCT05461235
- Sponsor
- China Medical University, China
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-15
- Primary completion
- 2025-07-15
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.